AYTU BIOPHARMA, INC Deferred Tax Assets, Deferred Income
AYTU BIOPHARMA, INC (AYTU) had Deferred Tax Assets, Deferred Income of $158.00 thousand as of 2015-06-30, per its 10-K filed 2015-09-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2015-09-28
- 2015-06-30: Deferred Tax Assets, Deferred Income $158.00K.
- 2014-06-30: Deferred Tax Assets, Deferred Income $190.00K.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2015-06-30 | $158.00K 10-K · filed 2015-09-28 |
| 2014-06-30 | $190.00K 10-K · filed 2015-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |